Home > PE Ratio > GENPHARMASEC

GENPHARMASEC
PE (Price/Earnings) Ratio

The Current P/E Ratio of GENPHARMASEC is 151.28.

Share Price ₹1.5Nov 07,2025
Market Cap ₹83.1 Cr
Earnings-TTM₹0.5 CrTTM-Consolidated Results
Price/Earnings151.28xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of GENPHARMASEC

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of GENPHARMASEC is calculated as :

Current Market Cap [ ₹83.1 Cr] as on Nov 07,2025

(/) Earnings [ ₹0.5 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 151.28x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for GENPHARMASEC , the investors are currently willing to pay 151.28 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GENPHARMASEC !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of GENPHARMASEC over the last five years.

Historical PE (Price/Earnings) ratio chart of GENPHARMASEC


PE Ratio Performance Analysis for GENPHARMASEC

- GENPHARMASEC 's latest p/e ratio is 151.28x.

- GENPHARMASEC 's p/e ratio for fiscal years ending Mar2025 to Mar2023 averaged 43.09x.

- GENPHARMASEC 's operated at median p/e ratio of 46x from fiscal years ending March 2018 to 2022.

- Looking back at the last 3 fiscal years, GENPHARMASEC 's p/e ratio peaked in Mar2025 at 83.26x.

- GENPHARMASEC 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does GENPHARMASEC 's P/E Ratio benchmark against top 10 peers in Dyes & Pigments Industry?

Peer Comparison (Dyes & Pigments Industry)Earnings-TTM (Cr)PE RatioMarket Cap
GENPHARMASEC 0.55151.2883.1
SUDARSHAN CHEMICAL INDUSTRIES LTD75.77111.688,461.6
KIRI INDUSTRIES LTD-208.39-15.613,253.2
VIDHI SPECIALTY FOOD INGREDIENTS LTD47.6534.001,620.0
SHREE PUSHKAR CHEMICALS & FERTILISERS LTD66.7319.061,271.8
BODAL CHEMICALS LTD29.2125.70750.8
BHAGERIA INDUSTRIES LTD48.8518.71913.9
DYNEMIC PRODUCTS LTD17.0421.89372.9
PODDAR PIGMENTS LTD17.8616.11287.7
ASAHI SONGWON COLORS LTD15.0821.18319.3
JAYSYNTH ORGOCHEM LTD14.4814.41208.6

Dyes & Pigments Industry Benchmark (Top 10) PE Analysis vs GENPHARMASEC 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE -15.61x
Max industry PE 151.28x
Median industry PE 21.18x
Average industry PE 38.04x



You may also like the below Video Courses